Literature DB >> 33922443

Daily Lifestyle Modifications to Improve Quality of Life and Survival in Glioblastoma: A Review.

Sarah Travers1, N Scott Litofsky1.   

Abstract

Survival in glioblastoma remains poor despite advancements in standard-of-care treatment. Some patients wish to take a more active role in their cancer treatment by adopting daily lifestyle changes to improve their quality of life or overall survival. We review the available literature through PubMed and Google Scholar to identify laboratory animal studies, human studies, and ongoing clinical trials. We discuss which health habits patients adopt and which have the most promise in glioblastoma. While results of clinical trials available on these topics are limited, dietary restrictions, exercise, use of supplements and cannabis, and smoking cessation all show some benefit in the comprehensive treatment of glioblastoma. Marital status also has an impact on survival. Further clinical trials combining standard treatments with lifestyle modifications are necessary to quantify their survival advantages.

Entities:  

Keywords:  cannabis use in glioblastoma; dietary restriction in glioblastoma; glioblastoma health modifications; supplementation in glioblastoma; survival in glioblastoma

Year:  2021        PMID： 33922443     DOI： 10.3390/brainsci11050533

Source DB:  PubMed          Journal:  Brain Sci        ISSN： 2076-3425


  122 in total

1.  Baseline levels of glucose metabolites, glutamate and glycerol in malignant glioma assessed by stereotactic microdialysis.

Authors:  Michael Roslin; Roger Henriksson; Per Bergström; Urban Ungerstedt; A Tommy Bergenheim
Journal:  J Neurooncol       Date:  2003-01       Impact factor: 4.130

2.  Potential effects of nicotine on glioblastoma and chemoradiotherapy: a review.

Authors:  Diane D McConnell; Steven B Carr; N Scott Litofsky
Journal:  Expert Rev Neurother       Date:  2019-05-17       Impact factor: 4.618

3.  Short-term calorie and protein restriction provide partial protection from chemotoxicity but do not delay glioma progression.

Authors:  Sebastian Brandhorst; Min Wei; Saewon Hwang; Todd E Morgan; Valter D Longo
Journal:  Exp Gerontol       Date:  2013-02-21       Impact factor: 4.032

4.  The effect of gamma-tocopherol on proliferation, integrin expression, adhesion, and migration of human glioma cells.

Authors:  Elika Samandari; Theresa Visarius; Jean-Marc Zingg; Angelo Azzi
Journal:  Biochem Biophys Res Commun       Date:  2006-02-28       Impact factor: 3.575

5.  Supplemental ascorbate in the supportive treatment of cancer: Prolongation of survival times in terminal human cancer.

Authors:  E Cameron; L Pauling
Journal:  Proc Natl Acad Sci U S A       Date:  1976-10       Impact factor: 11.205

6.  The synergy of Vitamin C with decitabine activates TET2 in leukemic cells and significantly improves overall survival in elderly patients with acute myeloid leukemia.

Authors:  Huihui Zhao; Huayuan Zhu; Jiayu Huang; Yu Zhu; Ming Hong; Han Zhu; Jingjing Zhang; Shan Li; Lijia Yang; Yun Lian; Shuai Wang; Jianping Mao; Yaoyu Chen; Jianyong Li; Sixuan Qian
Journal:  Leuk Res       Date:  2018-01-02       Impact factor: 3.156

7.  Effectiveness of Physical Therapy- and Occupational Therapy-Based Rehabilitation in People Who Have Glioma and Are Undergoing Active Anticancer Treatment: Single-Blind, Randomized Controlled Trial.

Authors:  Anders Hansen; Christian Bonde Pedersen; Jens Ole Jarden; Dagmar Beier; Lisbeth Rosenbek Minet; Karen Søgaard
Journal:  Phys Ther       Date:  2020-03-10

8.  Clinical trial participation and outcome for patients with glioblastoma: multivariate analysis from a comprehensive dataset.

Authors:  Kathryn M Field; Katharine J Drummond; Merve Yilmaz; Mark Tacey; Daniel Compston; Peter Gibbs; Mark A Rosenthal
Journal:  J Clin Neurosci       Date:  2013-04-29       Impact factor: 1.961

9.  Anticancer effects of novel NSAIDs derivatives on cultured human glioblastoma cells.

Authors:  Özlem Özdemir; Lisa Marinelli; Ivana Cacciatore; Michele Ciulla; Bugrahan Emsen; Antonio Di Stefano; Adil Mardinoglu; Hasan Turkez
Journal:  Z Naturforsch C J Biosci       Date:  2020-09-05

10.  The ketogenic diet is an effective adjuvant to radiation therapy for the treatment of malignant glioma.

Authors:  Mohammed G Abdelwahab; Kathryn E Fenton; Mark C Preul; Jong M Rho; Andrew Lynch; Phillip Stafford; Adrienne C Scheck
Journal:  PLoS One       Date:  2012-05-01       Impact factor: 3.240
View more
  3 in total

1.  The Impact of Resistance Exercise on Muscle Mass in Glioblastoma in Survivors (RESIST): Protocol for a Randomized Controlled Trial.

Authors:  Melanie R Keats; Scott A Grandy; Christopher Blanchard; Jonathon R Fowles; Heather F Neyedli; Adrienne C Weeks; Mary V MacNeil
Journal:  JMIR Res Protoc       Date:  2022-05-04

2.  Comparison of neutrophil to lymphocyte ratio and prognostic nutritional index with other clinical and molecular biomarkers for prediction of glioblastoma multiforme outcome.

Authors:  Celine Garrett; Therese M Becker; David Lynch; Joseph Po; Wei Xuan; Kieran F Scott; Paul de Souza
Journal:  PLoS One       Date:  2021-06-17       Impact factor: 3.240

3.  Red blood cell distribution width to platelet ratio substantiates preoperative survival prediction in patients with newly-diagnosed glioblastoma.

Authors:  Matthias Schneider; Niklas Schäfer; Stefanos Apallas; Anna-Laura Potthoff; Christian Bode; Erdem Güresir; Muriel Heimann; Felix Lehmann; Elisa Scharnböck; Christina Schaub; Hartmut Vatter; Ulrich Herrlinger; Patrick Schuss
Journal:  J Neurooncol       Date:  2021-08-04       Impact factor: 4.130
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.